RecruitingNCT05324488
Diabetes Registry Graz for Biomarker Research
Sponsor
Medical University of Graz
Enrollment
2,000 participants
Start Date
Oct 21, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect data, blood and urine samples of all subjects on an annual basis.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria10
- years
- Informed consent has to be given in written form
- At least one of the following diseases:
- Type 1 diabetes
- Type 2 diabetes
- Type 3 diabetes
- Maturity onset diabetes of young (MODY)
- Late onset diabetes of the adult (LADA)
- Adipositas (BMI \> 30kg/m2)
- Lipid metabolism disorder
Exclusion Criteria2
- No written informed consent
- No willingness to participate in this registry
Interventions
OTHERNo intervention
In this registry no intervention is carried out
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05324488
Related Trials
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
NCT0729648446 locations
Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
NCT071694221 location
Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
NCT068364791 location
High Intensity Interval Training and Insulin Sensitivity in Type 2 Diabetes
NCT066884611 location
IH, Brain Health, and T2D
NCT071735431 location